These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 8829021

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
    Boyle JE, Ghosh K, Gieser DK, Adamsons IA.
    Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1998 Oct; 105(10):1936-44. PubMed ID: 9787367
    [Abstract] [Full Text] [Related]

  • 6. A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study.
    Simpson AJ, Gray TB, Ballantyne C.
    Aust N Z J Ophthalmol; 1996 Feb; 24(1):39-42. PubMed ID: 8743003
    [Abstract] [Full Text] [Related]

  • 7. Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.
    Ormrod D, McClellan K.
    Drugs Aging; 2000 Dec; 17(6):477-96. PubMed ID: 11200308
    [Abstract] [Full Text] [Related]

  • 8. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE, Friren B, International Brinzolamide Adjunctive Study Group.
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [Abstract] [Full Text] [Related]

  • 9. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension.
    Heijl A, Strahlman E, Sverrisson T, Brinchman-Hansen O, Puustjärvi T, Tipping R.
    Ophthalmology; 1997 Jan; 104(1):137-42. PubMed ID: 9022118
    [Abstract] [Full Text] [Related]

  • 10. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
    Strahlman ER, Vogel R, Tipping R, Clineschmidt CM.
    Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
    [Abstract] [Full Text] [Related]

  • 11. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.
    J Glaucoma; 2009 Aug; 18(4):293-300. PubMed ID: 19365194
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
    García Sanchez J.
    Eur J Ophthalmol; 2000 Aug; 10(3):198-204. PubMed ID: 11071026
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension.
    Simmons ST, Alphagan/Trusopt Study Group.
    Clin Ther; 2001 Apr; 23(4):604-19. PubMed ID: 11354394
    [Abstract] [Full Text] [Related]

  • 17. Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension.
    Hartenbaum D, Maloney S, Vaccarelli L, Liss C, Wilson H, Gormley GJ.
    Clin Ther; 1999 Sep; 21(9):1533-8. PubMed ID: 10509848
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group.
    Rusk C, Sharpe E, Laurence J, Polis A, Adamsons I.
    Clin Ther; 1998 Sep; 20(3):454-66. PubMed ID: 9663361
    [Abstract] [Full Text] [Related]

  • 19. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I, Clineschmidt C, Polis A, Taylor J, Shedden A, Laibovitz R.
    J Glaucoma; 1998 Aug; 7(4):253-60. PubMed ID: 9713783
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.